Skip to main content
Premium Trial:

Request an Annual Quote

Biogazelle's microRNA Quantification Service

Biogazelle is now offering massively parallel sequencing to quantify microRNAs in compromised samples characterized by degraded RNA or low output amounts. The service offering comibnes optimal library preparation and purification, so that sequencing reads are actually spent on mature microRNAs, and not on undesirable contaminants such as ribosomal and other long RNA fragments, the company said. Further, raw data reads are processed and analyzed using Ant, Biogazelle's custom small RNA sequencing analysis pipeline that is part of Cobra, its RNA sequencing data-analysis platform.

Participants of the program will be able to send a representative sample that will be sequenced at very high coverage in order to determine the biomarker potential and optimal sequencing depth for future studies, Biogazelle said.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.